Sjs Investment Consulting Inc. Biocryst Pharmaceuticals Inc Transaction History

Sjs Investment Consulting Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$4.89 - $7.65 $9 - $15	2 Added 11.11%	20 $0
Q4 2023 Jan 16, 2024	SELL	$4.98 - $6.77 $34 - $47	-7 Reduced 28.0%	18 $0
Q3 2023 Oct 17, 2023	BUY	$6.71 - $7.92 $73 - $87	11 Added 78.57%	25 $0
Q1 2023 Apr 20, 2023	SELL	$7.94 - $11.84 $95 - $142	-12 Reduced 46.15%	14 $0
Q4 2022 Jan 23, 2023	BUY	$10.5 - $14.2 $147 - $198	14 Added 116.67%	26 $0
Q3 2022 Oct 13, 2022	BUY	$10.79 - $14.81 $107 - $148	10 Added 500.0%	12 $0
Q1 2022 May 05, 2022	BUY	$11.56 - $19.76 $23 - $39	2 New	2 $0

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.45B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

Stay updated on Sjs Investment Consulting Inc. with notifications on news.